Global Transdermal Patch Market - PowerPoint PPT Presentation

About This Presentation
Title:

Global Transdermal Patch Market

Description:

Bharat Book Bureau provides the report on “Global Transdermal Patch Market”, () The report highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies. – PowerPoint PPT presentation

Number of Views:177

less

Transcript and Presenter's Notes

Title: Global Transdermal Patch Market


1
Global Transdermal Patch Market
2
Summary
  • Global Transdermal Patch Market Clinical
    Pipeline Outlook 2022 report discusses the
    ongoing clinical and non-clinical parameters with
    respect to development of global transdermal
    patch market. Report highlights the need for
    integration of transdermal patches in existing
    drug delivery methodology available to
    pharmaceutical companies. Currently there 40
    transdermal patches available in the market and
    more than 70 patches are in clinical pipeline.
  • Transdermal patches have made their place in
    global market in past few decades as an
    alternative to conventional therapeutic for
    various disease indications. Systemic drug
    delivery could be achieved by oral and prenatal
    methods but they have several limitations due to
    which many patients often find them inconvenient.
    Pharmaceutical companies have identified these
    problems as an opportunity to develop transdermal
    patches for generating significant revenues. This
    problem was identified early and advancements in
    biotechnology helped in the introduction of
    transdermal patches in global market.

3
(No Transcript)
4
  • Nowadays, they are available for different
    disease indications and generally found suitable
    for large number of people having different
    disease indications. As a result, numbers of
    users are escalating at tremendous rates which
    are steadily increasing the global size.
  • Transdermal patches are widely accepted among
    physicians and patients due to their
    non-invasive, pain free and easy administration.
    In recent years, the growth of transdermal patch
    market has increased and expected to increase
    significantly in coming years. Higher investments
    in research and development could be attributed
    to the success of transdermal patch market.
    Number of disease indication treated by them is
    increasing steadily leading to higher market
    penetration. Every year various transdermal
    patches are introduced in globally leading to
    increased market size.
  • Transdermal patches presently donning the market
    are formulated in accordance with requirement of
    the medicinal therapy. They can be worn for as
    low as 8 hours to as long as 7 days depending on
    the therapeutic indication.

5
  • These patches are secured with adhesives, which
    are designed to adhere comfortably to the skin
    which in turn allows a patient to use the patches
    for as long as is indicated by his or her
    physician. Transdermal drug delivery provides
    excellent control of the rate of delivery
    directly into the bloodstream. It also offers a
    predictable pharmacokinetic profile and constant
    drug levels over extended periods of time without
    the extreme peak/trough fluctuations inherent in
    oral administration with the inherent power of
    discontinuation of therapy immediately by simply
    removing the patch.
  • Strong clinical pipeline could be observed in
    case of transdermal patches which reflect the
    interest of pharmaceutical companies in this
    segment. Before marketing approval they have to
    undergo strict testing and checking for various
    qualitative parameters. They must be stable,
    chemically unreactive, hypo allergic, nontoxic
    and easy to manufacture. High throughput methods
    are expected to increase the suitable polymer
    screening rates along with reduced time
    consumption. Bioequivalence of therapeutic in
    transdermal patch with same drug administrated
    via different route have known efficacy must be
    shown.

6
  • Similarly, independent of patch type they must
    show bioequivalence in clinical trials before
    getting marketing approval from medical
    regulatory authorities. Various products are at
    different stages of clinical trials which will be
    introduced in global market in coming years.

7
Full Reports
Global Transdermal Patch Market
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Email poonam_at_bharatbook.com O
ur Blog https//www.bharatbook.com/blog/ Twitter
https//twitter.com/researchbook Facebook
https//www.facebook.com/BharatBook3B LinkedIn
http//www.linkedin.com/company/bharat-book-bureau
8
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com